Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

NCT01179048 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9341

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: liraglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S